Inhibition of the α-ketoglutarate dehydrogenase complex by the myeloperoxidase products, hypochlorous acid and mono-N-chloramine

Journal of Neurochemistry

Volumn 92, Issue 2, 2005, Pages 302-310

  Jeitner, Thomas M ^a   Xu, Hui ^b   Gibson, Gary E ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

ketoglutarate dehydrogenase complex; Chloramine; Hypochlorous acid; Neurodegeneration

Indexed keywords

CHLORAMINE DERIVATIVE; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; MONO N CHLORAMINE; MYELOPEROXIDASE; OXOGLUTARATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; NERVE DEGENERATION; NEUROBLASTOMA CELL; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; THIAMINE DEFICIENCY;

ANIMALS; CELL LINE, TUMOR; CHLORAMINES; ENZYME ACTIVATION; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; KETOGLUTARATE DEHYDROGENASE COMPLEX; MICE; NEUROBLASTOMA; OXIDANTS; PEROXIDASE;

ANIMALIA;

EID: 13244298404     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02868.x     Document Type: Article

References (79)

1. Albrich J. M., McCarthy C. A. and Hurst J. K. (1981) Biological reactivity of hypochlorous acid: implications for microbicidal mechanisms of leukocyte myeloperoxidase. Proc. Natl Acad. Sci. USA 78, 210-214.
2. Andersen J. M., Myhre O., Aarnes H., Vestad T. A. and Fonnum F. (2003) Identification of the hydroxyl radical and other reactive oxygen species in human neutrophil granulocytes exposed to a fragment of the amyloid beta peptide. Free Rad Res. 37, 269-279.
3. Angelides K. J. and Hammes G. G. (1979) Structural and mechanistic studies of the alpha-ketoglutarate dehydrogenase multienzyme complex from Escherichia coli. Biochemistry 18, 5531-5537.
4. Antelo J. M., Arce F. and Parajo M. (2003) Kinetic study of the decomposition of N-chloramines. J. Phys Organic Chem. 9, 447-454.
5. Arendt T., Bigl V., Arendt A. and Tennstedt A. (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathologica 61, 101-108.
6. Aruoma O. I. and Halliwell B. (1987) Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase. Biochem. J. 248, 973-976.
7. Aune T. M. and Thomas E. L. (1977) Accumulation of hypothiocyanite ion during peroxidase-catalyzed oxidation of thiocyanate ion. European J. Biochem. 80, 209-214.
8. Bassett C. N. and Montine T. J. (2003) Lipoproteins and lipid peroxidation in Alzheimer's disease. J. Nutrition, Health Aging 7, 24-29.
9. Berridge M. V. and Tan A. S. (1993) Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophysics 303, 474-482.
10. Bokde A. L., Pietrini P., Ibanez V., Furey M. L., Alexander G. E., Graff-Radford N. R., Rapoport S. I., Schapiro M. B. and Horwitz B. (2001) The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease. Arch. Neurol. 58, 480-486.
11. Butterworth R. F. and Besnard A. M. (1990) Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease. Metabolic Brain Dis 5, 179-184.
12. Butterworth R. F., Kril J. J. and Harper C. G. (1993) Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke-Korsakoff syndrome. Alcoholism: Clin. Exp Res. 17, 1084-1088.
13. Calingasan N. Y., Gandy S. E., Baker H., Sheu K. F., Kim K. S., Wisniewski H. M. and Gibson G. E. (1995) Accumulation of amyloid precursor protein-like immunoreactivity in rat brain in response to thiamine deficiency. Brain Res. 677, 50-60.
14. Calingasan N. Y., Huang P. L., Chun H. S., Fabian A. and Gibson G. E. (2000) Vascular factors are critical in selective neuronal loss in an animal model of impaired oxidative metabolism. J. Neuropathol Exp Neurol. 59, 207-217.
15. Calingasan N. Y., Uchida K. and Gibson G. E. (1999) Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J. Neurochem. 72, 751-756.
16. Carr A. C. and Winterbourn C. C. (1997) Oxidation of neutrophil glutathione and protein thiols by myeloperoxidase-derived hypochlorous acid. Biochem. J. 327, 275-281.
17. Chang M. L., Klaidman L. K. and Adams J. D. Jr (1997) The effects of oxidative stress on in vivo brain GSH turnover in young and mature mice. Mol Chem. Neuropathol 30, 187-197.
18. Collier H. B. (1973) Letter: a note on the molar absorptivity of reduced Ellman's reagent, 3-carboxylato-4-nitrothiophenolate. Anal Biochem. 56, 310-311.
19. Combarros O., Infante J., Llorca J., Pena N., Fernandez-Viadero C. and Berciano J. (2002) The myeloperoxidase gene in Alzheimer's disease: a case-control study and meta-analysis. Neuroscience Lett. 326, 33-36.
20. Crawford F. C., Freeman M. J., Schinka J. A., Morris M. D., Abdullah L. I., Richards D., Sevush S., Duara R. and Mullan M. J. (2001) Association between Alzheimer's disease and a functional polymorphism in the Myeloperoxidase gene. Exp Neurol. 167, 456-459.
21. Cullen K. M. and Halliday G. M. (1995) Neurofibrillary tangles in chronic alcoholics. Neuropathol Appl. Neurobiol. 21, 312-318.
22. Folkes L. K., Candeias L. P. and Wardman P. (1995) Kinetics and mechanisms of hypochlorous acid reactions. Arch. Biochem. Biophysics 323, 120-126.
23. Gibson G. E., Ksiezak-Reding H., Sheu K. F., Mykytyn V. and Blass J. P. (1984) Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal. Neurochem. Res. 9, 803-814.
24. Gibson G. E., Sheu K. F., Blass J. P., Baker A., Carlson K. C., Harding B. and Perrino P. (1988) Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch. Neurol. 45, 836-840.
25. Gibson G. E., Nielsen P., Mykytyn V., Carlson K. and Blass J. (1989) Regionally selective alterations in enzymatic activities and metabolic fluxes during thiamin deficiency. Neurochem. Res. 14, 17-24.
26. Gibson G. E., Zhang H., Sheu K. F., Bogdanovich N., Lindsay J. G., Lannfelt L., Vestling M. and Cowburn R. F. (1998) Alpha-ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation. Ann. Neurol. 44, 676-681.
27. Gibson G. E., Park L. C., Sheu K. F., Blass J. P. and Calingasan N. Y. (2000) The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem. Int. 36, 97-112.
28. Gibson G. E., Zhang H., Xu H., Park L. C. and Jeitner T. M. (2002) Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme. Biochimica Biophysica Acta 1586, 177-189.
29. Gibson G. E., Kingsbury A. E., Xu H., Lindsay J. G., Daniel S., Foster O. J., Lees A. J. and Blass J. P. (2003) Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson's disease. Neurochem. Int. 43, 129-135.
30. Halliwell B. and Gutteridge J. M. C. (1989) Free Radicals in Biology and Medicine. Clarendon Press, Oxford.
31. Heneka M. T. and Feinstein D. L. (2001) Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 114, 8-18.
32. Heroux M., Raghavendra R. V., Lavoie J., Richardson J. S. and Butterworth R. F. (1996) Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer's disease. Metabolic Brain Dis 11, 81-88.
33. Hinerfeld D., Traini M. D., Weinberger R. P., Cochran B., Doctorw S. R., Harry J. and Melov S. (2004) Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. J. Neurochem. 88, 657-667.
34. Hoffmann S. C., Stanley E. M., Cox E. D., DiMercurio B. S., Koziol D. E., Harlan D. M., Kirk A. D. and Blair P. J. (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am. J. Transplantation 2, 560-567.
35. Jeitner T. M. and Lawrence D. A. (2000) Pulmonary autoimmunity and inflamation, in Pulmonary Immunotoxicology (Cohen, D. M., Zelikoff, J. T. and Schlesinger, R. B., eds), pp. 153-179. Kluwer Academic Publishers, Boston.
36. Klivenyi P., Starkov A. A., Calingasan N. Y., Gardian G., Browne S. E., Yang L., Bubber P., Gibson G. E., Patel M. S. and Beal M. F. (2004) Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropriopionic acid neurotoxicity. J. Neurochem. 88, 1352-1360.
37. Ko L. W., Sheu K. F., Thaler H. T., Markesbery W. R. and Blass J. P. (2001) Selective loss of KGDHC-enriched neurons in Alzheimer temporal cortex: does mitochondrial variation contribute to selective vulnerability? J. Mol Neuroscience 17, 361-369.
38. Kobayashi T., Matsumine H., Matuda S. and Mizuno Y. (1998) Association between the gene encoding the E2 subunit of the alpha-ketoglutarate dehydrogenase complex and Parkinson's disease. Ann. Neurol. 43, 120-123.
39. Law A., Gauthier S. and Quirion R. (2001) Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res. - Brain Res. Rev. 35, 73-96.
40. Leininger-Muller B., Hoy A., Herbeth B., Pfister M., Serot J. M., Stavljenic-Rukavina M., Massana L., Passmore P., Siest G. and Visvikis S. (2003) Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study. Neuroscience Lett. 349, 95-98.
41. Liu R. M. (2002) Down-regulation of gamma-glutamylcysteine synthetase regulatory subunit gene expression in rat brain tissue during aging. J. Neuroscience Res. 68, 344-351.
42. Lovell M. A., Xie C. and Markesbery W. R. (2001) Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 22, 187-194.
43. Lyras L., Cairns N. J., Jenner A., Jenner P. and Halliwell B. (1997) An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68, 2061-2069.
44. Maier K., Hinze H. and Holzer H. (1991) Inactivation of enzymes and an enzyme inhibitor by oxidative modification with chlorinated amines and metal-catalyzed oxidation systems. Biochimica Biophysica Acta 1079, 238-241.
45. Mastrogiacomo F. and Kish S. J. (1994) Cerebellar alpha-ketoglutarate dehydrogenase activity is reduced in spinocerebellar ataxia type 1. Ann. Neurol. 35, 624-626.
46. Mastrogiacomo F., Bergeron C. and Kish S. J. (1993) Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. J. Neurochem. 61, 2007-2014.
47. Mastrogiacoma F., Lindsay J. G., Bettendorff L., Rice J. and Kish S. J. (1996) Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. Ann. Neurol. 39, 592-598.
48. Minami M., Katsumata M., Miyake K., Inagaki H., Fan X. H., Kubota H., Yamano Y. and Kimura O. (1992) Dangerous mixture of household detergents in an old-style toilet: a case report with simulation experiments of the working environment and warning of potential hazard relevant to the general environment. Human Exp Toxicol. 11, 27-34.
49. Minami M., Inagaki H., Katsumata M., Miyake K. and Tomoda A. (1993) Inhibitory action of chloramine on formate-metabolizing system. Studies suggested by an unusual case record. Biochem. Pharmacol. 45, 1059-1064.
50. Mizuno Y., Matuda S., Yoshino H., Mori H., Hattori N. and Ikebe S. (1994) An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann. Neurol. 35, 204-210.
51. Murphy G. M. Jr, Yang L. and Cordell B. (1998) Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells. J. Biol. Chem. 273, 20 967-20 971.
52. Nagra R. M., Becher B., Tourtellotte W. W., Antel J. P., Gold D., Paladino T., Smith R. A., Nelson J. R. and Reynolds W. F. (1997) Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J. Neuroimmunol. 78, 97-107.
53. Nakamura M. and Yamazaki I. (1972) One-electron transfer reactions in biochemical systems. VI. Changes in electron transfer mechanism of lipoamide dehydrogenase by modification of sulfhydryl groups. Biochimica Biophysica Acta 267, 249-257.
54. Park L. C., Zhang H., Sheu K. F., Calingasan N. Y., Kristal B. S., Lindsay J. G. and Gibson G. E. (1999) Metabolic impairment induces oxidative stress, compromises inflammatory responses, and inactivates a key mitochondrial enzyme in microglia. J. Neurochem. 72, 1948-1958.
55. Park L. C., Calingasan N. Y., Sheu K. F. and Gibson G. E. (2000) Quantitative alpha-ketoglutarate dehydrogenase activity staining in brain sections and in cultured cells. Anal Biochem. 277, 86-93.
56. Park L. C., Albers D. S., Xu H., Lindsay J. G., Beal M. F. and Gibson G. E. (2001) Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy. J. Neuroscience Res. 66, 1028-1034.
57. Pennathur S., Jackson-Lewis V., Przedborski S. and Heinecke J. W. (1999) Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. J. Biol. Chem. 274, 34 621-34 628.
58. Peskin A. V. and Winterbourn C. C. (2001) Kinetics of the reactions of hypochlorous acid and amino acid chloramines with thiols, methionine, and ascorbate. Free Rad Biol. Med. 30, 572-579.
59. Picklo M. J., Montine T. J., Amarnath V. and Neely M. D. (2002) Carbonyl toxicology and Alzheimer's disease. Toxicol. Appl. Pharmacol. 184, 187-197.
60. Prutz W. A. (1996) Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates. Arch. Biochem. Biophysics 332, 110-120.
61. Prutz W. A. (1998) Interactions of hypochlorous acid with pyrimidine nucleotides, and secondary reactions of chlorinated pyrimidines with GSH, NADH, and other substrates. Arch. Biochem. Biophysics 349, 183-191.
62. Prutz W. A., Kissner R., Koppenol W. H. and Ruegger H. (2000) On the irreversible destruction of reduced nicotinamide nucleotides by hypohalous acids. Arch. Biochem. Biophysics 380, 181-191.
63. Pullar J. M., Winterbourn C. C. and Vissers M. C. (1999) Loss of GSH and thiol enzymes in endothelial cells exposed to sublethal concentrations of hypochlorous acid. Am. J. Physiol. 277, H1505-H1512.
64. Reynolds W. F., Rhees J., Maciejewski D., Paladino T., Sieburg H., Maki R. A. and Masliah E. (1999) Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp Neurol. 155, 31-41.
65. Reynolds W. F., Hiltunen M., Pirskanen M., Mannermaa A., Helisalmi S., Lehtovirta M., Alafuzoff I. and Soininen H. (2000) MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males. Neurology 55, 1284-1290.
66. Savage M. J., Iqbal M., Loh T., Trusko S. P., Scott R. and Siman R. (1994) Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein. Neuroscience 60, 607-619.
67. Schraufstatter I. U., Browne K., Harris A., Hyslop P. A., Jackson J. H., Quehenberger O. and Cochrane C. G. (1990) Mechanisms of hypochlorite injury of target cells. J. Clin. Invest 85, 554-562.
68. Shan X., Tashiro H. and Lin C. L. (2003) The identification and characterization of oxidized RNAs in Alzheimer's disease. J. Neuroscience 23, 4913-4921.
69. Sugiyama S., Okada Y., Sukhova G. K., Virmani R., Heinecke J. W. and Libby P. (2001) Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am. J. Pathol 158, 879-891.
70. Tabner B. J., Turnbull S., El Agnaf O. M. and Allsop D. (2002) Formation of hydrogen peroxide and hydroxyl radicals from A (beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease. Free Rad Biol. Med. 32, 1076-1083.
71. Tarkowski E., Andreasen N., Tarkowski A. and Blennow K. (2003) Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol., Neurosurgery Psychiatry 74, 1200-1205.
72. Terwel D., Bothmer J., Wolf E., Meng F. and Jolles J. (1998) Affected enzyme activities in Alzheimer's disease are sensitive to antemortem hypoxia. J. Neurol. Sci. 161, 47-56.
73. Thomas E. L., Grisham M. B. and Jefferson M. M. (1986) Preparation and characterization of chloramines. Meth Enzymol. 132, 569-585.
74. Tretter L. and Adam-Vizi V. (2000) Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J. Neuroscience 20, 8972-8979.
75. Vissers M. C. and Winterbourn C. C. (1995) Oxidation of intracellular glutathione after exposure of human red blood cells to hypochlorous acid. Biochem. J. 307, 57-62.
76. Winterbourn C. C. (1985) Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite. Biochimica Biophysica Acta 840, 204-210.
77. Winterbourn C. C. and Brennan S. O. (1997) Characterization of the oxidation products of the reaction between reduced glutathione and hypochlorous acid. Biochem. J. 326, 87-92.
78. Winterbourn C. C. and Metodiewa D. (1999) Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Rad Biol. Med. 27, 322-328.
79. Winterbourn C. C., van den Berg J. J., Roitman E. and Kuypers F. A. (1992) Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Arch. Biochem. Biophysics 296, 547-555.